For people suffering from various rare forms of blood cancer, acalabrutinib offers the promise of improved life quality by reducing serious side effects — namely suppressed immune systems that left ...

From 2023 to 2032, the global Bioanalytical Services market is projected to experience significant growth, driven by advancements in technology, increasing regulatory scrutiny, and the expanding ...

Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that its third batch of pharm ...

In a new study, a team of researchers, including Anneliene Jonker, has published, in Nature Reviews Drug Discovery, the first ...

Developed in exclusive collaboration with Hypatia, led by former Google engineer David Gordon, the asset leverages AI language.

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

Revenue Growth: Over the 3 months period, Evotec showcased positive performance, achieving a revenue growth rate of 6.96% as of 30 June, 2024. This reflects a substantial increase in the company's top ...

Lonza has continued to adapt to the evolving ADC landscape, including the recent addition of a highly potent vial fill ...

The influence of AI in drug development has gained such importance that it has been termed a revolution. Let’s explore how ...

For the first time, chemists have managed to create a type of molecule that was previously thought to be too unstable to ...

| While artificial intelligence is on everyone’s minds and in many R&D plans, adoption of generative AI has been slow so far ...